Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Arm Study Followed by an Open-Label Arm toEvaluate the Efficacy and Safety of Efgartigimod IV in AdultParticipants With Primary Immune Thrombocytopenia

Project: Research project

Project Details

Description

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
StatusActive
Effective start/end date6/16/25 → 6/16/35

Funding

  • ARGENX BV

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint